Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

19-04-2024(Fri) 18-04-2024(Thu) 17-04-2024(Wed) 16-04-2024(Tue) 15-04-2024(Mon)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes *Advertisement*
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
20 Nov, 2014 (Thursday)

            
DYNAGREEN ENV(1330)
Analysis¡G
Dynagreen Environmental Protection (1330) recently announced the signing of franchise agreement for the construction a garbage power plant in Yulin City, China Bobai County, Guangxi Province, following the successful bidder of garbage incineration power generation projects in early September in Chaoyang District, Shantou City, Guangdong Province. The garbage power plant project uses "Building - operate - transfer" (BOT) investment, concession period of 30 years. Project size for the daily processing was 1,500 tons garbage, which will implemented in three phases, of which the first phase had daily processing of 700 tons garbage. The estimated total investmentthe of first phase was about RMB 280 million. (I do not hold the above stock)
Strategy¡G
Buy-in Price: $5.35, Target Price: $5.85, Cut Loss Price: $5.15

FOSUN PHARMA(2196)
Analysis¡G
The Stock launched for three days, which the reaction was unexpectedly very poor. The trading volume of HK stocks continued to decline from the first day of over $80 billion to $65 billion yesterday. Although we are still optimistic about the long-term benefits bring by the linking of the two markets, in short term we may need to cut loss and wait to see any turnaround. However, some A + H shares rose yesterday, among them Fosun Pharmaceutical (2196) increased more than 7% with high turnover. There was reports earlier pointed out that mainland health care policy was not favoured to the mainland pharmaceutical stocks, especially may cancel the medicine-compensate-treatment system in the past. The integrated medical group may be more likely to benefit from future policy.
Strategy¡G
Buy-in Price: $27.50, Target Price: $30.00, Cut Loss Price: $26.50


Brilliance China (1114.HK) - It may slow down in a short time, but will not impact the long term advantage

-BMW group announced the result in the third quarter of 2014. Its investment returns up 37% yoy to 170 million Euros, corresponding to RMB 1.3 billion Yuan. According to our estimation, the investment returns contributed by BMW Brilliance in the third quarter will amount to RMB 1.4 billion Yuan, and the cumulative investment returns contributed in the first three quarters will exceed 5 billion Yuan, corresponding to EPS before tax about 1.01 Yuan, which indicates that the result in the first three quarters has already exceeded the result in the full year of last year by around 40%.

-BMW Brilliance has totally delivered about 70 thousand units in the third quarter of 2014, strongly upping 33% yoy, while the growth in the first two quarters was respectively 51% and 26%. SUV model X1 ups 94% yoy to 11.9 thousand units and 3-SERIS ups 73% yoy to 24.8 thousand units, while 5-SERIS was basically flat, slightly upping 3.2% to 33.6 thousand units.

How we view this

Based on three causes, we believe that the growth ratio of BMW Brilliance will slow down in a short term. However, in terms of a middle and long run, benefited from the major background of improving localization and updating consumption, we are still positive about premium cars' future development in China. We think that at the moment, it is hard to substantially change the approach of domestic premium cars' sales system in a short time, namely, the anti-monopoly investigation and parallel import have a slight influence on the powerful position of OEM car manufacturers, which, on the opposite, is good for BMW Brilliance to speed up its nationalization so as to highlight its cost advantage

Investment Action

According to above, we lowered our target price to HK$15.67, based on 12.3/10.7/8.8xP/E in2014/2015/2016, but raise the rating to ¡§buy¡¨.

Result of BMW Brilliance in the third quarter continues to have a rapid growth

BMW group announced the result in the third quarter of 2014. Its investment returns up 37% yoy to 170 million Euros, corresponding to RMB 1.3 billion Yuan. According to our estimation, the investment returns contributed by BMW Brilliance in the third quarter will amount to RMB 1.4 billion Yuan, and the cumulative investment returns contributed in the first three quarters will exceed 5 billion Yuan, corresponding to EPS before tax about 1.01 Yuan, which indicates that the result in the first three quarters has already exceeded the result in the full year of last year by around 40%.

Sales momentums remain robust

BMW Brilliance has totally delivered about 70 thousand units in the third quarter of 2014, strongly upping 33% yoy, while the growth in the first two quarters was respectively 51% and 26%. Benefiting from the expanded production capacity, 3-SERIS and X1 were the detailed segments which had the rapidest growth judging from vehicle models. SUV model X1 ups 94% yoy to 11.9 thousand units in the third quarter this year, and 3-SERIS ups 73% yoy to 24.8 thousand units.

On the other hand, due to the limited production capacity of Dadong plant, the sales volume of 5-SERIS in the third quarter was basically flat, slightly upping 3.2% to 33.6 thousand units. Before the expansion project is put into operation, we believe that the increment of BMW Brilliance's sales volume will be still mainly contributed by 3-SERIS and X1 in a short period of time.

The company's sales target in 2014 is 260 thousand units, up over 30% yoy, and the sales volume achieved in the first three quarters has accounted for 80.8% of the target, so it will be a high probability event to outperform the target for the year.

Production capacity expansion advances steadily

In order to successfully implement the new future strategy planning issued in July this year and expand the production line of domestic car models, the promotion work of BMW Brilliance's total production capacity is being steadily carried out. The expansion engineering of Dadong plant is planned to be accomplished in April next year. By the end of 2015, the total production ability of BMW Brilliance in Shenyang will be raised from the current 300 thousand units per year to 400 thousand units per year. And it is hopefully to be continuously raised to 600 thousand units approximately in 2016.

After the new engine factory of BMW Brilliance is built, three-cylinder and four-cylinder gasoline engines will be officially put into production in 2016, supporting the new future small cars' introduction. This will have positive promotion effects on Brilliance BMW's production amount and profits.

It may slow down in a short time, but will not impact the long term advantage

Based on the following causes, we believe that the growth ratio of BMW Brilliance will slow down in a short term:

1) The nearest new model, 2-series, will not be released until the fourth quarter of 2015; the new generation of X1 is likely to be launched in 2016; the new generation of the fifth series is planned to be launched in 2017. In a short period, there is a lack of new models.

2) Confronted with competitors' challenges, (for instance, competitive new models of Benz and Audi are released one after another), BMW¡¦s dealers are under a growing pressure of de-stocking and price-off promotions.

3) The expansion project of Dadong factory is in progress, which may affect the 5-series¡¦ ' production ability.However, in terms of a middle and long run, benefited from the major background of improving localization and updating consumption, we are still positive about premium cars' future development in China. We think that at the moment, it is hard to substantially change the approach of domestic premium cars' sales system in a short time, namely, the anti-monopoly investigation and parallel import have a slight influence on the powerful position of OEM car manufacturers, which, on the opposite, is good for BMW Brilliance to speed up its nationalization so as to highlight its cost advantage.

Valuation

We believe that, after experiencing the explosive growth in past few years, the increase rate of China's luxury car market begins to slow down, with structure-based and pluralism market development trend becoming apparent, so BMW's accelerated introduction of segmentation products is conducive to continuous development of new segment markets.According to above, we lowered our target price to HK$15.67, based on 12.3/10.7/8.8xP/E in2014/2015/2016, but raise the rating to ¡§buy¡¨.

Click Here for PDF format...




Recommendation on 20-11-2014
RecommendationBuy
Price on Recommendation Date$ 12.580
Suggested purchase priceN/A
Target Price$ 15.670
Writer Info
Zhang Jing
(Research Analyst)
Tel: +86 63512937-104
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre


Stock Borrowing & Lending



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Phillip Research - Hong Kong ½÷¥ß¬ã¨s³¡ ¡V ­»´ä¤Î¤¤°ê
Company Stock Code Last Update Suggestion Target Price Price on Recom
Mainland Financial Xingyu Chen (86) 2151698900-105chenxingyu@phillip.com.cn
Huishang Bank369818/11/2014Buy4.13.34
China Construction Bank93931/10/2014Accumulate6.55.72
Transportation and Automobiles Zhang Jing (86) 2151699200-103zhangjing@phillip.com.cn
Brilliance China111420/11/2014Buy15.670.000
GAC Group223813/11/2014Accumulate8.527.47
Mainland Property Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
China South City166804/11/2014Buy5.53.52
Wanda Commercial Properties Group16929/09/2014Accumulate21.73
Insurance Xingyu Chen (86) 2151699400-105chenxingyu@phillip.com.cn
CPIC260111/11/2014Buy33.728.1
New China Insurance133615/08/2014Buy36.628
Properties  
FORTUNE REIT77814/10/2014Accumulate7.326.92
China State Construction International Holdings Ltd331116/05/2014Buy15.813.16
Hotels and Entertainment Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
Galaxy Entertainment2719/11/2014Accumulate5651.75
Galaxy Entertainment2716/07/2014Accumulate7262.95
New Energy  
Xinjiang Goldwind220810/11/2014Accumulate15.5613.46
China Suntien Green Energy95621/10/2014Buy2.331.93
Food, Beverage and Retail  
Samsonite International SA191012/11/2014Accumulate3127
Sa Sa International17816/09/2014Reduce5.075.81
Telecommunications  
AAC Technologies201817/11/2014Accumulate48.5543.85
BYD Electronic28507/11/2014Buy10.788.84
Oil and Gas Geng Chen (86) 2151699400-107chengeng@phillip.com.cn
CIMC ENRIC389927/10/2014Buy107.67
Anton Oilfield Service333710/10/2014Neutral2.22.29
Software & Service Kay Ng (852) 2277 6751kayng@phillip.com.hk
BOYAA43414/11/2014Accumulate8.527.39
HC INTERNATIONAL228006/11/2014Buy14.928.8

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2014 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]